NCT06982261

Brief Summary

This study aims to test a new technology-based program designed to help improve the ability to manage chronic conditions. This program includes daily smart speaker use for managing different tasks and technology learning. Proper self-management of chronic conditions is critical to the maintenance of health. Digital technologies offer substantial potential to enhance self-management behaviors. Voice-operated smart speakers hold promise due to their ability to provide functional, cognitive, and social stimulation, send targeted reminders, and assist with daily schedules. Unfortunately, many older adults who live in low-income communities lack the resources and proficiency to take advantage of these options. Additionally, cognitive impairment is prevalent in independent living older adults, more prevalent in low-income older adults. The goal is to address these critical challenges by identifying smart speaker-based functions preferred by older adults, exploring their technology challenges, introducing them to these functions, and providing necessary technology training to improve self-efficacy in managing chronic conditions and enhance their engagement in self-management behaviors.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 13, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 21, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

July 15, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
Last Updated

July 23, 2025

Status Verified

July 1, 2025

Enrollment Period

11 months

First QC Date

May 13, 2025

Last Update Submit

July 18, 2025

Conditions

Keywords

Low income older adultsArtificial IntelligenceVoice activated smart speakers (SS)

Outcome Measures

Primary Outcomes (7)

  • Retention Rate

    Retention rate will be measured by the number of individuals who continue participating in a program for up 3 months

    3 months

  • System Usability Scale

    Acceptance will be measured using the System Usability Scale (SUS) that is a widely used, validated tool for measuring the perceived usability of a system (e.g., software, website, device). It consists of 10 items, each rated on a 5-point Likert scale ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). The researcher will modify the wording slightly to make the questions appropriate for the technology system being evaluated. Score \> 68: Above average usability Score = 68: Average usability benchmark Score \< 68: Below average usability

    Baseline, 2 months, and 3 months

  • Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank v1.0 Self-Efficacy for Managing Chronic Conditions - Managing Medications and Treatment

    The PROMIS Item Bank v1.0 Self-Efficacy measure assesses self-reported current level of confidence in managing chronic conditions, with a focus on managing medications and treatment regimen related to chronic health conditions. It consists of 26 items, each rated on a 5-point Likert scale ranging from 1 (not at all confident) to 5 (very confident). Raw scores (sum of item responses) are converted to T-scores using the PROMIS scoring system. A score of 50 is the average for the United States general population, with a standard deviation of 10. Higher T-scores indicate greater self-efficacy in managing medications and treatment.

    Baseline, 2 months, and 3 months

  • Self-Care of Chronic Illness Inventory (V.4C)

    The Self-Care of Chronic Illness Inventory (SC-CII) version 4c is a validated tool designed to assess self-care behaviors in individuals managing chronic illnesses. Each item within the SC-CII is rated on a 5-point Likert scale, typically ranging from 1 ("Never") to 5 ("Always"). It evaluates self-care across three key domains: Self-Care Maintenance (Section A), Self-Care Monitoring (Section B), and Self-Care Management (Section C). Also, it examines Self-Care Confidence (Section D). Scores for each domain are calculated by summing the item responses within that domain. Higher scores indicate better self-care behaviors in the respective domain. A standardized score of 70 or above in any domain is generally considered indicative of adequate self-care. Scores below 70 may suggest areas where the individual could benefit from additional support or intervention to enhance self-care practices.

    Baseline, 2 months, and 3 months

  • Modified Computer Self-Efficacy Scale

    Modified Computer Self-Efficacy Scale (mCSES) is a modification of Compeau and Higgins 10-item Computer Self-Efficacy Scale, developed to make it applicable for clinical settings (for use with older people or people with disabilities using everyday technologies). The questions ask to indicate whether "you could use this unfamiliar technology under a variety of conditions". Rated on a 10-point scale of confidence. Principal components analysis yields a two-factor structure: 1. Using the Technology Alone (e.g., "If there was no one around to tell me what to do as I go"), and 2. Using the Technology with the Support of Others (e.g., " If someone else had helped me get started"). Participants with higher levels of technology self-efficacy would be more frequent users of everyday technology.

    Baseline, 2 months, and 3 months

  • Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Adult Profile questionnaire

    The PROMIS-29 Adult Profile measure assesses pain intensity using a single 0-10 numeric pain rating item and seven health domains using four items each: physical functioning, fatigue, pain interference, depression, anxiety, ability to participate in social roles and activities, and sleep disturbance. Each item is rated on a Likert-type scale, typically 1 (not at all) to 5 (very much), with response options indicating the frequency or severity of symptoms or experiences. For most PROMIS instruments, a score of 50 is the average for the United States general population, with a standard deviation of 10. Higher scores for Depression, Fatigue, Sleep Disturbance, and Pain Interference indicate worse health than average.

    Baseline, 2 months, and 3 months

  • Engagement in Self-Management Behaviors determined by smart speaker interaction logs

    The research team will extract the text-based Alexa usage data showing verbal commands used by each participant to examine types of verbal commands, frequency, and regularity of smart speaker use to determine participants' engagement in self-management behaviors.

    2 months and 3 months

Secondary Outcomes (1)

  • Factors affecting the implementation and dissemination of the Voice2Manage

    2 months and 3 months

Study Arms (1)

Voice-activated smart speakers

EXPERIMENTAL

Participants will complete a set of standardized questionnaires. A list of smart speaker-based tasks will be introduced. Participants will then be asked to choose three tasks from a list.

Other: Voice-activated smart speakers

Interventions

Participants will attend a single 90 to 120-minute in-person baseline visit to complete standardized questionnaires and review a list of smart speaker-based tasks. They will select three tasks; all will receive an Echo Show and a Fitbit Versa. Additional digital health devices (e.g., blood pressure monitor, in-home motion sensors) will be provided based on their selections. Participants will learn to interact with Alexa, followed by a second home visit one week later for task-specific setup and device installation. The team will conduct weekly or bi-weekly check-in calls for two months, with additional home visits as needed. At two months, a home visit will include questionnaires and a 30-60 minute interview on intervention feasibility. Participants will then use the devices independently for one month, with a final home visit at three months for questionnaires and a closing interview.

Voice-activated smart speakers

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Persons 55 years of age and older,
  • Living in subsidized housing or with a housing voucher and having an annual income less than $30K,
  • One or more chronic conditions,
  • Having probable mild cognitive impairment (MCI), based on the education-adjusted Montreal Cognitive Assessment (MoCA) score less than 24 and greater than or equal to 18,
  • Living alone independently, and
  • Able to speak and read English.

You may not qualify if:

  • Severe visual/hearing impairment requiring assistance in participating in interactions with the smart speaker and integrated devices,
  • Self-reported diagnoses of Alzheimer's disease and related dementias,
  • Significant medical illness interfering with the study assessments and activities,
  • Inability to provide informed consent, and
  • Nursing home residents.
  • Eligibility will not be limited to smart speaker ownership.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory University

Atlanta, Georgia, 30329, United States

RECRUITING

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Jane Chung, PhD, RN

    Emory University - Nell Hodgson Woodruff School of Nursing

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jane Chung, PhD, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Acting Associate Professor

Study Record Dates

First Submitted

May 13, 2025

First Posted

May 21, 2025

Study Start

July 15, 2025

Primary Completion

June 1, 2026

Study Completion

June 1, 2026

Last Updated

July 23, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be made available to qualified researchers.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data will be available after publication.
Access Criteria
Requests will be reviewed by the study's PI. Approved requesters will receive data through a secure data transfer platform following execution of a data use agreement.

Locations